人类噬菌体治疗的免疫应答综述
本综述探讨哺乳动物对噬菌体的免疫应答,重点聚焦人类对治疗性噬菌体的免疫反应及其对噬菌体治疗结局的潜在影响。尽管噬菌体在人类微生物组(尤其肠道噬菌体组)中普遍存在,但支配对内源性和治疗性噬菌体免疫应答的免疫学机制研究仍处于起步阶段。文章强调参与体内噬菌体清除的关键免疫系统组分,并审视患者个体变量、治疗方案和噬菌体特征等因素如何影响免疫应答及治疗中的噬菌体药代动力学。
要点
- 人类对治疗性噬菌体的免疫应答可能影响噬菌体治疗的药代动力学和临床结局。
- 患者个体变量、治疗方案和噬菌体特征均可调节免疫应答。
- 亟需深入理解人类对噬菌体的免疫应答以指导个性化噬菌体治疗开发。
核心结论
- clearer understanding of human immune responses to phages is urgently needed to inform the development of more targeted and effective personalized phage therapies-an essential step in combating the escalating threat of antimicrobial resistance.
研究设计与样本
- 本文为综述,探讨哺乳动物对噬菌体的免疫应答,尤其关注人类对治疗性噬菌体的免疫应答及其对治疗结局的潜在影响。
主要发现
- 噬菌体在人类微生物组中普遍存在,尤其肠道噬菌体组,但关于内源性和治疗性噬菌体免疫应答的免疫学机制研究仍处于起步阶段。
- 综述强调了参与体内噬菌体清除的关键免疫系统组分。
- 患者个体变量、治疗方案和噬菌体特征等因素可影响免疫应答,进而影响治疗中的噬菌体药代动力学。
临床怎么用
- 临床应关注患者个体变量、治疗方案和噬菌体特征对免疫应答及噬菌体药代动力学的影响,以优化个性化噬菌体治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This review explores mammalian immune responses to phages with a particular emphasis on human immune responses to therapeutic phages and their potential implications for the outcomes of phage therapy. Despite the ubiquity of phages in the human microbiome, particularly in the gut (the phageome), research on immunological mechanisms governing immune responses to both endogenous and therapeutic phages are still in their infancy. We highlight key components of the immune system that contribute to clearance of phages in vivo and examine how various factors- including patient-specific variables, treatment regimens and phage characteristics can influence immune responses and, consequently, phage pharmacokinetics during therapy. A clearer understanding of human immune responses to phages is urgently needed to inform the development of more targeted and effective personalized phage therapies-an essential step in combating the escalating threat of antimicrobial resistance.
引用
- Bosco K, Fabijan AP, Iredell J, et al. Immune Responses to Phage Therapy in Humans: A Review. J Infect Dis. 2026. PMID: 41685961. doi:10.1093/infdis/jiag096
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。